Premium
COVID‐19 vaccines and the role of other potential allergenic components different from PEG. A reply to: “Other excipients than PEG might cause serious hypersensitivity reactions in COVID‐19 vaccines”
Author(s) -
Cabanillas Beatriz,
Akdis Cezmi A.,
Novak Natalija
Publication year - 2021
Publication title -
allergy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.363
H-Index - 173
eISSN - 1398-9995
pISSN - 0105-4538
DOI - 10.1111/all.14761
Subject(s) - covid-19 , european commission , medicine , allergy , virology , immunology , disease , infectious disease (medical specialty) , european union , business , pathology , outbreak , economic policy